Human Genome Epidemiology Literature Finder
Pinterest
| Filtered By: |
|
Previous |
Records 1 - 30 (of 85 Records) |
| Query Trace: Neoplasms and HOXB13[original query] |
|---|
| Pathogenic Germline DNA Repair Gene and HOXB13 Mutations in Men With Metastatic Prostate Cancer. JCO precision oncology 2020 4 . Boyle Julie L, Hahn Andrew W, Kapron Ashley L, Kohlmann Wendy, Greenberg Samantha E, Parnell Timothy J, Teerlink Craig C, Maughan Benjamin L, Feng Bing-Jian, Cannon-Albright Lisa, Agarwal Neeraj, Cooney Kathleen 
|
A Large-Scale Association Study Detects Novel Rare Variants, Risk Genes, Functional Elements, and Polygenic Architecture of Prostate Cancer Susceptibility.
Cancer research 2020 12 81 (7): 1695-1703. Emami Nima C, Cavazos Taylor B, Rashkin Sara R, Cario Clinton L, Graff Rebecca E, Tai Caroline G, Mefford Joel A, Kachuri Linda, Wan Eunice, Wong Simon, Aaronson David, Presti Joseph, Habel Laurel A, Shan Jun, Ranatunga Dilrini K, Chao Chun R, Ghai Nirupa R, Jorgenson Eric, Sakoda Lori C, Kvale Mark N, Kwok Pui-Yan, Schaefer Catherine, Risch Neil, Hoffmann Thomas J, Van Den Eeden Stephen K, Witte John 
|
| Observed evidence for guideline-recommended genes in predicting prostate cancer risk from a large population-based cohort. The Prostate 2021 7 81 (13): 1002-1008. Wei Jun, Yang Wancai, Shi Zhuqing, Lu Lucy, Wang Qiang, Resurreccion W Kyle, Engelmann Valentina, Zheng S Lilly, Hulick Peter J, Cooney Kathleen A, Isaacs William B, Helfand Brian T, Lu Jim, Xu Jianfe 
|
| Prostate cancer risk variants of the HOXB genetic locus. Scientific reports 2021 May 11 (1): 11385. Dupont William D, Breyer Joan P, Johnson Spenser H, Plummer W Dale, Smith Jeffrey 
|
| Combined Effect of a Polygenic Risk Score and Rare Genetic Variants on Prostate Cancer Risk. European urology 2021 5 80 (2): 134-138. Darst Burcu F, Sheng Xin, Eeles Rosalind A, Kote-Jarai Zsofia, Conti David V, Haiman Christopher
|
| Characteristics of Germline Non-BRCA Mutation Status of High-Risk Breast Cancer Patients in China and Correlation with High-Risk Factors and Multigene Testing Suggestions. Frontiers in genetics 2021 12 12 674094. Su Yifan, Yao Qianlan, Xu Yuyin, Yu Chengli, Zhang Jing, Wang Qian, Li Jiwei, Shi Di, Yu Baohua, Zeng Yupeng, Zhu Xiaoli, Bai Qianming, Zhou Xiaoy 
|
| The HOXB13 variant X285K is associated with clinical significance and early age at diagnosis in African American prostate cancer patients. British journal of cancer 2021 11 126 (5): 791-796. Na Rong, Wei Jun, Sample Chris J, Gielzak Marta, Choi Sodam, Cooney Kathleen A, Rabizadeh Daniel, Walsh Patrick C, Zheng Lilly S, Xu Jianfeng, Isaacs William
|
| Massive parallel sequencing in individuals with multiple primary tumours reveals the benefit of re-analysis. Hereditary cancer in clinical practice 2021 10 19 (1): 46. Wallander Karin, Thonberg Håkan, Nilsson Daniel, Tham Em 
|
| Variants in HOXB13, G132E and F127C, Are Associated With Prostate Cancer Risk in Japanese Men. Cancer diagnosis & prognosis 0 2 (5): 542-548. Kurihara Sota, Matsui Hiroshi, Ohtake Nobuaki, Aoki Masanori, Sekine Yoshitaka, Arai Seiji, Koike Hidekazu, Suzuki Kazuhiro, Miyazawa Yoshiyu |
| Prognostic significance of pathogenic variants in BRCA1, BRCA2, ATM and PALB2 genes in men undergoing hormonal therapy for advanced prostate cancer. British journal of cancer 2022 Aug . Kimura Hiroko, Mizuno Kei, Shiota Masaki, Narita Shintaro, Terada Naoki, Fujimoto Naohiro, Ogura Keiji, Hatano Shotaro, Iwasaki Yusuke, Hakozaki Nozomi, Ishitoya Satoshi, Sumiyoshi Takayuki, Goto Takayuki, Kobayashi Takashi, Nakagawa Hidewaki, Kamoto Toshiyuki, Eto Masatoshi, Habuchi Tomonori, Ogawa Osamu, Momozawa Yukihide, Akamatsu Shusu 
|
| Germline Mutations in Patients With Early-Onset Prostate Cancer. Frontiers in oncology 2022 6 12 826778. Tang Tang, Tan Xintao, Wang Ze, Wang Shuo, Wang Yapeng, Xu Jing, Wei Xiajie, Zhang Dianzheng, Liu Qiuli, Jiang J
|
| Germline pathogenic variants in unselected Korean men with prostate cancer. Investigative and clinical urology 2022 05 63 (3): 294-300. So Min-Kyung, Ahn Hyun Kyu, Huh Jungwon, Kim Kwang Hy
|
| Clinical Significance of Gene Mutations and Polymorphic Variants and their Association with Prostate Cancer Risk in Polish Men. Cancer control : journal of the Moffitt Cancer Center 2022 5 29 10732748211062342. Heise Marta, Jarzemski Piotr, Nowak Dagmara, B?k Aneta, Junkiert-Czarnecka Anna, Pilarska-Deltow Maria, Borysiak Maciej, Pilarska Beata, Haus Ol |
| Inherited risk assessment and its clinical utility for predicting prostate cancer from diagnostic prostate biopsies. Prostate cancer and prostatic diseases 2022 3 25 (3): 422-430. Xu Jianfeng, Resurreccion W Kyle, Shi Zhuqing, Wei Jun, Wang Chi-Hsiung, Zheng S Lilly, Hulick Peter J, Ross Ashley E, Pavlovich Christian P, Helfand Brian T, Isaacs William
|
| Clinical Utility of Germline Genetic Testing in Japanese Men Undergoing Prostate Biopsy. JNCI cancer spectrum 2022 02 6 (1): . Akamatsu Shusuke, Terada Naoki, Takata Ryo, Kinoshita Hidefumi, Shimatani Kimihiro, Momozawa Yukihide, Yamamoto Michio, Tada Harue, Kawamorita Naoki, Narita Shintaro, Kato Takuma, Nitta Masahiro, Kandori Shuya, Koike Yusuke, Inazawa Johji, Kimura Takahiro, Kimura Hiroko, Kojima Takahiro, Terachi Toshiro, Sugimoto Mikio, Habuchi Tomonori, Arai Yoichi, Yamamoto Shingo, Matsuda Tadashi, Obara Wataru, Kamoto Toshiyuki, Inoue Takahiro, Nakagawa Hidewaki, Ogawa Osa
|
| Germline Variants in DNA Damage Repair Genes and HOXB13 Among Black Patients With Early-Onset Prostate Cancer. JCO precision oncology 2022 11 6 e2200460. Trendowski Matthew R, Sample Christopher, Baird Tara, Sadeghpour Azita, Moon David, Ruterbusch Julie J, Beebe-Dimmer Jennifer L, Cooney Kathleen 
|
| Canonical and uncanonical pathogenic germline variants in colorectal cancer patients by next-generation sequencing in a European referral center. ESMO open 2022 11 7 (6): 100607. Poliani L, Greco L, Barile M, Dal Buono A, Bianchi P, Basso G, Giatti V, Genuardi M, Malesci A, Laghi L, |
| Germline HOXB13 mutation p.G84E do not confer an increased bladder or kidney cancer risk in polish population. Hereditary cancer in clinical practice 2022 1 20 (1): 1. Z?owocka-Per?owska El?bieta, To?oczko-Grabarek Aleksandra, Lubi?ski J
|
| A Rare Germline HOXB13 Variant Contributes to Risk of Prostate Cancer in Men of African Ancestry. European urology 2022 1 81 (5): 458-462. Darst Burcu F, Hughley Raymond, Pfennig Aaron, Hazra Ujani, Fan Caoqi, Wan Peggy, Sheng Xin, Xia Lucy, Andrews Caroline, Chen Fei, Berndt Sonja I, Kote-Jarai Zsofia, Govindasami Koveela, Bensen Jeannette T, Ingles Sue A, Rybicki Benjamin A, Nemesure Barbara, John Esther M, Fowke Jay H, Huff Chad D, Strom Sara S, Isaacs William B, Park Jong Y, Zheng Wei, Ostrander Elaine A, Walsh Patrick C, Carpten John, Sellers Thomas A, Yamoah Kosj, Murphy Adam B, Sanderson Maureen, Crawford Dana C, Gapstur Susan M, Bush William S, Aldrich Melinda C, Cussenot Olivier, Petrovics Gyorgy, Cullen Jennifer, Neslund-Dudas Christine, Kittles Rick A, Xu Jianfeng, Stern Mariana C, Chokkalingam Anand P, Multigner Luc, Parent Marie-Elise, Menegaux Florence, Cancel-Tassin Geraldine, Kibel Adam S, Klein Eric A, Goodman Phyllis J, Stanford Janet L, Drake Bettina F, Hu Jennifer J, Clark Peter E, Blanchet Pascal, Casey Graham, Hennis Anselm J M, Lubwama Alexander, Thompson Ian M, Leach Robin J, Gundell Susan M, Pooler Loreall, Mohler James L, Fontham Elizabeth T H, Smith Gary J, Taylor Jack A, Brureau Laurent, Blot William J, Biritwum Richard, Tay Evelyn, Truelove Ann, Niwa Shelley, Tettey Yao, Varma Rohit, McKean-Cowdin Roberta, Torres Mina, Jalloh Mohamed, Magueye Gueye Serigne, Niang Lamine, Ogunbiyi Olufemi, Oladimeji Idowu Michael, Popoola Olufemi, Adebiyi Akindele O, Aisuodionoe-Shadrach Oseremen I, Nwegbu Maxwell, Adusei Ben, Mante Sunny, Darkwa-Abrahams Afua, Yeboah Edward D, Mensah James E, Anthony Adjei Andrew, Diop Halimatou, Cook Michael B, Chanock Stephen J, Watya Stephen, Eeles Rosalind A, Chiang Charleston W K, Lachance Joseph, Rebbeck Timothy R, Conti David V, Haiman Christopher 
|
| Somatic and Germline Variants Affect Prognosis and Susceptibility in Prostate Cancer. Anticancer research 2023 6 43 (7): 2941-2949. Christian Rocca, Giulia Rocca, Pietro Zampieri, Lucio Dell'atti, Nicoletta Bianchi, Carmelo Ippolito, Gianluca Aguia |
| Clinicopathological Characteristics and Mutational Landscape of APC, HOXB13, and KRAS among Rwandan Patients with Colorectal Cancer. Current issues in molecular biology 2023 5 45 (5): 4359-4374. Felix Manirakiza, Eric Rutaganda, Hidetaka Yamada, Yuji Iwashita, Belson Rugwizangoga, Benoit Seminega, Vincent Dusabejambo, Gervais Ntakirutimana, Deogratias Ruhangaza, Annette Uwineza, Kazuya Shinmura, Haruhiko Sugimu |
| Germline DNA-Repair Genes and HOXB13 Mutations in Korean Men with Metastatic Prostate Cancer: Data from a Large Korean Cohort. The world journal of men's health 2023 4 . Sang Hun Song, Hak-Min Kim, Yu Jin Jung, Ha Rim Kook, Sungwon Jeon, Jong Bhak, Jin Hyuck Kim, Hakmin Lee, Jong Jin Oh, Sangchul Lee, Sung Kyu Hong, Seok-Soo By |
| Potential prognostic role of somatic mutations in a set of cancer susceptibility genes in ovarian carcinoma: A follow-up multicentric study from Pakistan. Cancer biomarkers : section A of Disease markers 2023 2 . Masood Atika, Sarfaraz Rahat, Zaki Saima, Shami Amira, Khaliq Saba, Naseem Nad
|
| Whole exome germline sequencing in early-onset prostate cancer patients: Genomic findings and clinical outcomes. The Prostate 2023 10 . Nava Siegelmann-Danieli, Victoria Neiman, Avital Bareket-Samish, Racheli Berger, Asaf Peretz, Hillel Alapi, Erez Tsur, Tal Patalon, Daniella Beller, Galit Rimler, Gabriel Chodick, Mordechai Shoh |
| Evaluation of homeobox protein B13 (HOXB13) gene G84E mutation in patients with prostate cancer. World journal of urology 2024 8 42 (1): 476. Melih B?y?ko?lu, Rojda Tanr?verdi, Murat Bozlu, Samet ?enel, ?enay Balc? Fidanc?, Lülüfer Tamer, Erdem Akb |
| Plasma microRNA Signature as Companion Diagnostic for Abiraterone Acetate Treatment in Metastatic Castration-Resistant Prostate Cancer: A Pilot Study. International journal of molecular sciences 2024 6 25 (11): . Simone Detassis, Francesca Precazzini, Margherita Grasso, Valerio Del Vescovo, Francesca Maines, Orazio Caffo, Paola Campomenosi, Michela A Den 
|
| Characterising the contribution of rare protein-coding germline variants to prostate cancer risk and severity in 37,184 cases. medRxiv : the preprint server for health sciences 2024 5 . Jonathan Mitchell, Niedzica Camacho, Patrick Shea, Konrad H Stopsack, Vijai Joseph, Oliver Burren, Ryan Dhindsa, Abhishek Nag, Jacob E Berchuck, Amanda O'Neill, Ali Abbasi, Anthony W Zoghbi, Jesus Alegre-Díaz, Pablo Kuri-Morales, Jaime Berumen, Roberto Tapia-Conyer, Jonathan Emberson, Jason M Torres, Rory Collins, Quanli Wang, David Goldstein, Athena Matakidou, Carolina Haefliger, Lauren Anderson-Dring, Ruth March, Vaidehi Jobanputra, Brian Dougherty, Keren Carss, Slavé Petrovski, Philip W Kantoff, Kenneth Offit, Lorelei A Mucci, Mark Pomerantz, Margarete A Fab
|
| ERBB2/HOXB13 co-amplification with interstitial loss of BRCA1 defines a unique subset of breast cancers. Breast cancer research : BCR 2024 12 26 (1): 185. Irene Rin Mitsiades, Maristela Onozato, A John Iafrate, Daniel Hicks, Do?a C Gülhan, Dennis C Sgroi, Esther Rheinb |
| Prevalence and Distribution of Unexpected Actionable Germline Pathogenic Variants Identified on Broad-Based Multigene Panel Testing Among Patients With Cancer. JCO precision oncology 2024 12 8 e2400553. Kara K Landry, Michael J DeSarno, Lindsay Kipnis, Farid Barquet Ramos, Katelyn M Breen, Kaleigh Patton, Audrey Morrissette, Ryan M Buehler, Chinedu Ukaegbu, Mersedeh Rohanizadegan, Matthew B Yurgelun, Sapna Syngal, Huma Q Rana, Judy E Garb
|
| Study of HOXB13 Gene Variants in Prostate Cancer Patients. Cureus 2024 11 16 (10): e72513. Kazhal M Sulaiman, Rebwar M Hama Sal |
- Page last reviewed:Feb 1, 2024
- Content source: